Form 8-K - Current report:
SEC Accession No. 0001013762-25-003407
Filing Date
2025-03-27
Accepted
2025-03-27 16:30:55
Documents
16
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0235200-8k_therap.htm   iXBRL 8-K 29595
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MARCH 27, 2025, ENTITLED THERAPEU ea023520001ex99-1_therap.htm EX-99.1 13202
3 GRAPHIC image_001.jpg GRAPHIC 7474
4 GRAPHIC image_001.gif GRAPHIC 49
  Complete submission text file 0001013762-25-003407.txt   231881

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE txmd-20250327.xsd EX-101.SCH 3033
6 XBRL LABEL FILE txmd-20250327_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE txmd-20250327_pre.xml EX-101.PRE 22371
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0235200-8k_therap_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 25779907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)